MEDIA
|
23 March, 2021
Times of India – 19th March, 2021
RDIF and Stelis Biopharma tie up for Sputnik V vaccine Read more at: http://timesofindia.indiatimes.com/articleshow/81589850.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst MUMBAI: Russia’s sovereign wealth fund, Russ...
READ MORE
|
23 March, 2021
Indian Express – March 19, 2021
Bengaluru-based Stelis Biopharma to make 200 million doses of Sputnik V Covid vaccine Stelis Biopharma, the biopharmaceutical arm of Bengaluru-headquartered...
READ MORE
|
03 February, 2015
Wall Street Journal – 2013
Wall Street Journal - 2013 GE Venture to Upgrade Hospital Equipment in India State - By Sudeep Jain MUMBAI—A consortium...
READ MORE